Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7733953

Concept 2017-03-01 to
2017-08-31
2016-03-01 to
2016-08-31
Consolidated statement of income
Statement of income
Net sales
73,463,000,000 JPY
74,447,000,000 JPY
Cost of sales
27,584,000,000 JPY
26,193,000,000 JPY
Operating expenses
Selling, general and administrative expenses
33,249,000,000 JPY
35,378,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
399,000,000 JPY
167,000,000 JPY
Net sales
Gross profit (loss)
45,878,000,000 JPY
48,254,000,000 JPY
Operating profit (loss)
12,629,000,000 JPY
12,875,000,000 JPY
Ordinary profit (loss)
12,869,000,000 JPY
12,554,000,000 JPY
Operating expenses
Research and development expenses
7,935,000,000 JPY
7,791,000,000 JPY
Extraordinary income
487,000,000 JPY
1,303,000,000 JPY
Non-operating income
Interest income
180,000,000 JPY
101,000,000 JPY
Dividend income
403,000,000 JPY
377,000,000 JPY
Other
248,000,000 JPY
187,000,000 JPY
Non-operating income
849,000,000 JPY
682,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
5,774,000,000 JPY
5,351,000,000 JPY
Non-operating expenses
Interest expenses
15,000,000 JPY
18,000,000 JPY
Other
10,000,000 JPY
22,000,000 JPY
Non-operating expenses
609,000,000 JPY
1,002,000,000 JPY
Extraordinary losses
2,000,000 JPY
46,000,000 JPY
Loss on disposal of non-current assets
2,000,000 JPY
46,000,000 JPY
Profit (loss) before income taxes
13,354,000,000 JPY
13,812,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
487,000,000 JPY
0 JPY
Extraordinary losses
Income taxes
3,809,000,000 JPY
4,421,000,000 JPY
Profit (loss)
9,545,000,000 JPY
9,391,000,000 JPY
Profit (loss) attributable to non-controlling interests
158,000,000 JPY
104,000,000 JPY
Profit (loss) attributable to owners of parent
9,386,000,000 JPY
9,286,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,736,000,000 JPY
-2,146,000,000 JPY
Foreign currency translation adjustment
-2,289,000,000 JPY
-8,026,000,000 JPY
Remeasurements of defined benefit plans, net of tax
131,000,000 JPY
188,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
5,000,000 JPY
-103,000,000 JPY
Other comprehensive income
-415,000,000 JPY
-10,002,000,000 JPY
Profit attributable to
Comprehensive income
9,129,000,000 JPY
-611,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
8,984,000,000 JPY
-676,000,000 JPY
Comprehensive income attributable to non-controlling interests
145,000,000 JPY
65,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.